Enveric Biosciences, Inc. (ENVB) vs NeuroSense Therapeutics Ltd. (NRSN)
A side-by-side comparison of Enveric Biosciences, Inc. and NeuroSense Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENVB
Enveric Biosciences, Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
NRSN
NeuroSense Therapeutics Ltd.
$4.01HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — ENVB vs NRSN
growth of $100 · dividends reinvested · last 4yENVB -100.0% (-85.1%/yr)NRSN -78.2% (-31.7%/yr)NRSN compounded faster over this window
Log scale — wide-divergence pair
ENVB NRSN
ENVB vs NRSN: by the numbers
- •NRSN is the larger company ($7M vs $7M market cap).
Metrics side by side
Valuation
| Metric | ENVB | NRSN |
|---|---|---|
| P/B ratio | 0.81 | N/A |
Profitability
| Metric | ENVB | NRSN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -108.00% | N/A |
| ROIC | -107.99% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.